KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
Abstract Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) positive, progesterone receptor (PR) positive, human epidermal growth factor receptor 2 (HER2) positive, and trip...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2024-05-01
|
| סדרה: | Molecular Cancer |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12943-024-02011-0 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
